TRAMADOL Drug Patent Profile
✉ Email this page to a colleague
When do Tramadol patents expire, and when can generic versions of Tramadol launch?
Tramadol is a drug marketed by Actavis Elizabeth, Aurobindo Pharma Ltd, Lupin Ltd, Macleods Pharms Ltd, Mylan, Ph Health, Strides Pharma Intl, Sun Pharm, Accord Hlthcare, Amneal Pharms, Apotex, Asta, Cspc Ouyi Pharm Co, Graviti Pharms, Ipca Labs Ltd, Ivax Sub Teva Pharms, Mylan Pharms Inc, Northstar Hlthcare, Pliva, Puracap Labs Blu, Rubicon, Rubicon Research, Senores Pharms, Specgx Llc, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Unichem, Watson Labs, Alkem Labs Ltd, Aurobindo Pharma, Chartwell Rx, Micro Labs Ltd India, Mpp Pharma, Rising, and Zydus Pharms Usa Inc. and is included in forty-five NDAs.
The generic ingredient in TRAMADOL is acetaminophen; tramadol hydrochloride. There are sixty-six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the acetaminophen; tramadol hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRAMADOL?
- What are the global sales for TRAMADOL?
- What is Average Wholesale Price for TRAMADOL?
Summary for TRAMADOL
| US Patents: | 0 |
| Applicants: | 37 |
| NDAs: | 45 |
| Drug Prices: | Drug price information for TRAMADOL |
| Drug Sales Revenues: | Drug sales revenues for TRAMADOL |
| DailyMed Link: | TRAMADOL at DailyMed |



